APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radiopharmaceutical

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Selected research

Industry Growth & Trends

Global Radiopharmaceutical Industry Growth and Trends Forecast to 2032

25 December 2025118 pages

Choose your research edition.

Industry ResearchRadiopharmaceutical Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiopharmaceutical Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Radiopharmaceutical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiopharmaceutical Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiopharmaceutical Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

The global Radiopharmaceutical top three manufacturers include the Bracco Imaging, Bayer and Mallinckrodt, with about 47% market shares. North America and Europe is the main consumption places, with a consumption market share nearly 45% and 27%.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Radiopharmaceutical market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Radiopharmaceutical market size, estimates, and forecasts are presented in terms of sales volume (M Doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Radiopharmaceutical market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Radiopharmaceutical.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Radiopharmaceutical market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Radiopharmaceutical Market by Company

Bracco Imaging

Bayer

Mallinckrodt

Nordion

Triad Isotopes

Lantheus

IBA Group

GE Healthcare

China Isotope & Radiation

Jubilant Pharma

Eli Lilly

Advanced Accelerator Applications

SIEMENS

Dongcheng

Navidea

Radiopharmaceutical Segment by Type

Actinium-225

Lutetium-177

Radium-223

Holmium-166

Other

Radiopharmaceutical Segment by Application

Oncology

Cardiology

Other

Radiopharmaceutical Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceutical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Radiopharmaceutical manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Radiopharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Actinium-225 Table 2. Major Company of Lutetium-177 Table 3. Major Company of Radium-223 Table 4. Major Company of Holmium-166 Table 5. Major Company of Other Table 6. Global Radiopharmaceutical Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Radiopharmaceutical Sales by Type (2021-2026) & (M Doses) Table 8. Global Radiopharmaceutical Sales Market Share in Volume by Type (2021-2026) Table 9. Global Radiopharmaceutical Sales by Type (2021-2026) & (US$ Million) Table 10. Global Radiopharmaceutical Sales Market Share in Value by Type (2021-2026) Table 11. Global Radiopharmaceutical Price by Type (2021-2026) & (USD/Dose) Table 12. Global Radiopharmaceutical Sales by Type (2027-2032) & (M Doses) Table 13. Global Radiopharmaceutical Sales Market Share in Volume by Type (2027-2032) Table 14. Global Radiopharmaceutical Sales by Type (2027-2032) & (US$ Million) Table 15. Global Radiopharmaceutical Sales Market Share in Value by Type (2027-2032) Table 16. Global Radiopharmaceutical Price by Type (2027-2032) & (USD/Dose) Table 17. North America Radiopharmaceutical Sales by Type (2021-2026) & (M Doses) Table 18. North America Radiopharmaceutical Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Radiopharmaceutical Sales by Type (2021-2026) & (M Doses) Table 20. Europe Radiopharmaceutical Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Radiopharmaceutical Sales by Type (2021-2026) & (M Doses) Table 22. Asia-Pacific Radiopharmaceutical Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Radiopharmaceutical Sales by Type (2021-2026) & (M Doses) Table 24. Latin America Radiopharmaceutical Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Radiopharmaceutical Sales by Type (2021-2026) & (M Doses) Table 26. Middle East and Africa Radiopharmaceutical Sales by Type (2021-2026) & (US$ Million) Table 27. Radiopharmaceutical Industry Trends Table 28. Radiopharmaceutical Industry Drivers Table 29. Radiopharmaceutical Industry Opportunities and Challenges Table 30. Radiopharmaceutical Industry Restraints Table 31. Global Radiopharmaceutical Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Radiopharmaceutical Revenue Market Share by Company (2021-2026) Table 33. Global Radiopharmaceutical Sales by Company (2021-2026) & (M Doses) Table 34. Global Radiopharmaceutical Sales Share by Company (2021-2026) Table 35. Global Radiopharmaceutical Market Price by Company (2021-2026) & (USD/Dose) Table 36. Global Radiopharmaceutical Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Radiopharmaceutical Major Company Production Sites and Headquarters Table 38. Global Radiopharmaceutical Company, Product Type & Application Table 39. Global Radiopharmaceutical Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Radiopharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Radiopharmaceutical Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Radiopharmaceutical Sales by Region (2021-2026) & (M Doses) Table 44. Global Radiopharmaceutical Sales Market Share in Volume by Region (2021-2026) Table 45. Global Radiopharmaceutical Sales by Region (2021-2026) & (US$ Million) Table 46. Global Radiopharmaceutical Sales Market Share in Value by Region (2021-2026) Table 47. Global Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 48. Global Radiopharmaceutical Sales by Region (2027-2032) & (M Doses) Table 49. Global Radiopharmaceutical Sales Market Share in Volume by Region (2027-2032) Table 50. Global Radiopharmaceutical Sales by Region (2027-2032) & (US$ Million) Table 51. Global Radiopharmaceutical Sales Market Share in Value by Region (2027-2032) Table 52. Global Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2027-2032) Table 53. Global Radiopharmaceutical Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Radiopharmaceutical Sales by Application (2021-2026) & (M Doses) Table 55. Global Radiopharmaceutical Sales Market Share in Volume by Application (2021-2026) Table 56. Global Radiopharmaceutical Sales by Application (2021-2026) & (US$ Million) Table 57. Global Radiopharmaceutical Sales Market Share in Value by Application (2021-2026) Table 58. Global Radiopharmaceutical Price by Application (2021-2026) & (USD/Dose) Table 59. Global Radiopharmaceutical Sales by Application (2027-2032) & (M Doses) Table 60. Global Radiopharmaceutical Sales Market Share in Volume by Application (2027-2032) Table 61. Global Radiopharmaceutical Sales by Application (2027-2032) & (US$ Million) Table 62. Global Radiopharmaceutical Sales Market Share in Value by Application (2027-2032) Table 63. Global Radiopharmaceutical Price by Application (2027-2032) & (USD/Dose) Table 64. North America Radiopharmaceutical Sales by Application (2021-2026) & (M Doses) Table 65. North America Radiopharmaceutical Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Radiopharmaceutical Sales by Application (2021-2026) & (M Doses) Table 67. Europe Radiopharmaceutical Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Radiopharmaceutical Sales by Application (2021-2026) & (M Doses) Table 69. Asia-Pacific Radiopharmaceutical Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Radiopharmaceutical Sales by Application (2021-2026) & (M Doses) Table 71. Latin America Radiopharmaceutical Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Radiopharmaceutical Sales by Application (2021-2026) & (M Doses) Table 73. Middle East and Africa Radiopharmaceutical Sales by Application (2021-2026) & (US$ Million) Table 74. Bracco Imaging Company Information Table 75. Bracco Imaging Business Overview Table 76. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 77. Bracco Imaging Radiopharmaceutical Product Portfolio Table 78. Bracco Imaging Recent Development Table 79. Bayer Company Information Table 80. Bayer Business Overview Table 81. Bayer Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 82. Bayer Radiopharmaceutical Product Portfolio Table 83. Bayer Recent Development Table 84. Mallinckrodt Company Information Table 85. Mallinckrodt Business Overview Table 86. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 87. Mallinckrodt Radiopharmaceutical Product Portfolio Table 88. Mallinckrodt Recent Development Table 89. Nordion Company Information Table 90. Nordion Business Overview Table 91. Nordion Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 92. Nordion Radiopharmaceutical Product Portfolio Table 93. Nordion Recent Development Table 94. Triad Isotopes Company Information Table 95. Triad Isotopes Business Overview Table 96. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 97. Triad Isotopes Radiopharmaceutical Product Portfolio Table 98. Triad Isotopes Recent Development Table 99. Lantheus Company Information Table 100. Lantheus Business Overview Table 101. Lantheus Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 102. Lantheus Radiopharmaceutical Product Portfolio Table 103. Lantheus Recent Development Table 104. IBA Group Company Information Table 105. IBA Group Business Overview Table 106. IBA Group Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 107. IBA Group Radiopharmaceutical Product Portfolio Table 108. IBA Group Recent Development Table 109. GE Healthcare Company Information Table 110. GE Healthcare Business Overview Table 111. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 112. GE Healthcare Radiopharmaceutical Product Portfolio Table 113. GE Healthcare Recent Development Table 114. China Isotope & Radiation Company Information Table 115. China Isotope & Radiation Business Overview Table 116. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 117. China Isotope & Radiation Radiopharmaceutical Product Portfolio Table 118. China Isotope & Radiation Recent Development Table 119. Jubilant Pharma Company Information Table 120. Jubilant Pharma Business Overview Table 121. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 122. Jubilant Pharma Radiopharmaceutical Product Portfolio Table 123. Jubilant Pharma Recent Development Table 124. Eli Lilly Company Information Table 125. Eli Lilly Business Overview Table 126. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 127. Eli Lilly Radiopharmaceutical Product Portfolio Table 128. Eli Lilly Recent Development Table 129. Advanced Accelerator Applications Company Information Table 130. Advanced Accelerator Applications Business Overview Table 131. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 132. Advanced Accelerator Applications Radiopharmaceutical Product Portfolio Table 133. Advanced Accelerator Applications Recent Development Table 134. SIEMENS Company Information Table 135. SIEMENS Business Overview Table 136. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 137. SIEMENS Radiopharmaceutical Product Portfolio Table 138. SIEMENS Recent Development Table 139. Dongcheng Company Information Table 140. Dongcheng Business Overview Table 141. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 142. Dongcheng Radiopharmaceutical Product Portfolio Table 143. Dongcheng Recent Development Table 144. Navidea Company Information Table 145. Navidea Business Overview Table 146. Navidea Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 147. Navidea Radiopharmaceutical Product Portfolio Table 148. Navidea Recent Development Table 149. North America Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 150. North America Radiopharmaceutical Sales by Country (2021-2026) & (M Doses) Table 151. North America Radiopharmaceutical Sales Market Share by Country (2021-2026) Table 152. North America Radiopharmaceutical Sales Forecast by Country (2027-2032) & (M Doses) Table 153. North America Radiopharmaceutical Sales Market Share Forecast by Country (2027-2032) Table 154. North America Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. North America Radiopharmaceutical Market Size by Country (2021-2026) & (US$ Million) Table 156. North America Radiopharmaceutical Market Share by Country (2021-2026) Table 157. North America Radiopharmaceutical Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. North America Radiopharmaceutical Market Share Forecast by Country (2027-2032) Table 159. Europe Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 160. Europe Radiopharmaceutical Sales by Country (2021-2026) & (M Doses) Table 161. Europe Radiopharmaceutical Sales Market Share by Country (2021-2026) Table 162. Europe Radiopharmaceutical Sales Forecast by Country (2027-2032) & (M Doses) Table 163. Europe Radiopharmaceutical Sales Market Share Forecast by Country (2027-2032) Table 164. Europe Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Europe Radiopharmaceutical Market Size by Country (2021-2026) & (US$ Million) Table 166. Europe Radiopharmaceutical Market Share by Country (2021-2026) Table 167. Europe Radiopharmaceutical Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Europe Radiopharmaceutical Market Share Forecast by Country (2027-2032) Table 169. Asia-Pacific Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 170. Asia-Pacific Radiopharmaceutical Sales by Country (2021-2026) & (M Doses) Table 171. Asia-Pacific Radiopharmaceutical Sales Market Share by Country (2021-2026) Table 172. Asia-Pacific Radiopharmaceutical Sales Forecast by Country (2027-2032) & (M Doses) Table 173. Asia-Pacific Radiopharmaceutical Sales Market Share Forecast by Country (2027-2032) Table 174. Asia-Pacific Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 175. Asia-Pacific Radiopharmaceutical Market Size by Country (2021-2026) & (US$ Million) Table 176. Asia-Pacific Radiopharmaceutical Market Share by Country (2021-2026) Table 177. Asia-Pacific Radiopharmaceutical Market Size Forecast by Country (2027-2032) & (US$ Million) Table 178. Asia-Pacific Radiopharmaceutical Market Share Forecast by Country (2027-2032) Table 179. Latin America Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 180. Latin America Radiopharmaceutical Sales by Country (2021-2026) & (M Doses) Table 181. Latin America Radiopharmaceutical Sales Market Share by Country (2021-2026) Table 182. Latin America Radiopharmaceutical Sales Forecast by Country (2027-2032) & (M Doses) Table 183. Latin America Radiopharmaceutical Sales Market Share Forecast by Country (2027-2032) Table 184. Latin America Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 185. Latin America Radiopharmaceutical Market Size by Country (2021-2026) & (US$ Million) Table 186. Latin America Radiopharmaceutical Market Share by Country (2021-2026) Table 187. Latin America Radiopharmaceutical Market Size Forecast by Country (2027-2032) & (US$ Million) Table 188. Latin America Radiopharmaceutical Market Share Forecast by Country (2027-2032) Table 189. Middle East and Africa Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 190. Middle East and Africa Radiopharmaceutical Sales by Country (2021-2026) & (M Doses) Table 191. Middle East and Africa Radiopharmaceutical Sales Market Share by Country (2021-2026) Table 192. Middle East and Africa Radiopharmaceutical Sales Forecast by Country (2027-2032) & (M Doses) Table 193. Middle East and Africa Radiopharmaceutical Sales Market Share Forecast by Country (2027-2032) Table 194. Middle East and Africa Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 195. Middle East and Africa Radiopharmaceutical Market Size by Country (2021-2026) & (US$ Million) Table 196. Middle East and Africa Radiopharmaceutical Market Share by Country (2021-2026) Table 197. Middle East and Africa Radiopharmaceutical Market Size Forecast by Country (2027-2032) & (US$ Million) Table 198. Middle East and Africa Radiopharmaceutical Market Share Forecast by Country (2027-2032) Table 199. Key Raw Materials Table 200. Raw Materials Key Suppliers Table 201. Radiopharmaceutical Distributors List Table 202. Radiopharmaceutical Customers List Table 203. Research Programs/Design for This Report Table 204. Authors List of This Report Table 205. Secondary Sources Table 206. Primary Sources List of Figures Figure 1. Radiopharmaceutical Image Figure 2. Global Radiopharmaceutical Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiopharmaceutical Market Size (2021-2032) & (US$ Million) Figure 4. Global Radiopharmaceutical Sales (2021-2032) & (M Doses) Figure 5. Actinium-225 Image Figure 6. Global Actinium-225 Sales YoY Growth (2021-2032) & (M Doses) Figure 7. Lutetium-177 Image Figure 8. Global Lutetium-177 Sales YoY Growth (2021-2032) & (M Doses) Figure 9. Radium-223 Image Figure 10. Global Radium-223 Sales YoY Growth (2021-2032) & (M Doses) Figure 11. Holmium-166 Image Figure 12. Global Holmium-166 Sales YoY Growth (2021-2032) & (M Doses) Figure 13. Other Image Figure 14. Global Other Sales YoY Growth (2021-2032) & (M Doses) Figure 15. Global Radiopharmaceutical Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Radiopharmaceutical Market Share by Type 2025 VS 2032 Figure 17. North America Radiopharmaceutical Sales Market Share in Volume by Type in 2025 Figure 18. North America Radiopharmaceutical Sales Market Share in Value by Type in 2025 Figure 19. Europe Radiopharmaceutical Sales Market Share in Volume by Type in 2025 Figure 20. Europe Radiopharmaceutical Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Radiopharmaceutical Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Radiopharmaceutical Sales Market Share in Value by Type in 2025 Figure 23. Latin America Radiopharmaceutical Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Radiopharmaceutical Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Radiopharmaceutical Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Radiopharmaceutical Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Radiopharmaceutical Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Oncology Image Figure 30. Global Oncology Sales YoY Growth (2021-2032) & (M Doses) Figure 31. Cardiology Image Figure 32. Global Cardiology Sales YoY Growth (2021-2032) & (M Doses) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (M Doses) Figure 35. Global Radiopharmaceutical Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Radiopharmaceutical Market Share by Application 2025 VS 2032 Figure 37. North America Radiopharmaceutical Sales Market Share in Volume by Application in 2025 Figure 38. North America Radiopharmaceutical Sales Market Share in Value by Application in 2025 Figure 39. Europe Radiopharmaceutical Sales Market Share in Volume by Application in 2025 Figure 40. Europe Radiopharmaceutical Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Radiopharmaceutical Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Radiopharmaceutical Sales Market Share in Value by Application in 2025 Figure 43. Latin America Radiopharmaceutical Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Radiopharmaceutical Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Radiopharmaceutical Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Radiopharmaceutical Sales Market Share in Value by Application in 2025 Figure 47. North America Radiopharmaceutical Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 48. North America Radiopharmaceutical Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Radiopharmaceutical Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Radiopharmaceutical Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Radiopharmaceutical Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 52. Europe Radiopharmaceutical Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Radiopharmaceutical Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Radiopharmaceutical Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Radiopharmaceutical Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 56. Asia-Pacific Radiopharmaceutical Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Radiopharmaceutical Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Radiopharmaceutical Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Radiopharmaceutical Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 60. Latin America Radiopharmaceutical Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Radiopharmaceutical Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Radiopharmaceutical Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Radiopharmaceutical Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 64. Middle East and Africa Radiopharmaceutical Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Radiopharmaceutical Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Radiopharmaceutical Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Radiopharmaceutical Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Radiopharmaceutical Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Actinium-225
  • Lutetium-177
  • Radium-223
  • Holmium-166
  • Other
Applications
  • Oncology
  • Cardiology
  • Other
Companies covered
  • Bracco Imaging
  • Bayer
  • Mallinckrodt
  • Nordion
  • Triad Isotopes
  • Lantheus
  • IBA Group
  • GE Healthcare
  • China Isotope & Radiation
  • Jubilant Pharma
  • Eli Lilly
  • Advanced Accelerator Applications
  • SIEMENS
  • Dongcheng
  • Navidea

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Radiopharmaceutical Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Radiopharmaceutical Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Radiopharmaceutical Market by Type
  6. 1.3.1 Actinium-225
  7. 1.3.2 Lutetium-177
  8. 1.3.3 Radium-223
  9. 1.3.4 Holmium-166
  10. 1.3.5 Other
  11. 1.4 Global Radiopharmaceutical Market Size by Type
  12. 1.4.1 Global Radiopharmaceutical Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Radiopharmaceutical Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Radiopharmaceutical Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Radiopharmaceutical Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Radiopharmaceutical Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Radiopharmaceutical Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Radiopharmaceutical Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Radiopharmaceutical Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Radiopharmaceutical Industry Trends
  2. 2.2 Radiopharmaceutical Industry Drivers
  3. 2.3 Radiopharmaceutical Industry Opportunities and Challenges
  4. 2.4 Radiopharmaceutical Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Radiopharmaceutical Revenue (2021-2026)
  2. 3.2 Global Top Players by Radiopharmaceutical Sales (2021-2026)
  3. 3.3 Global Top Players by Radiopharmaceutical Price (2021-2026)
  4. 3.4 Global Radiopharmaceutical Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Radiopharmaceutical Major Company Production Sites & Headquarters
  6. 3.6 Global Radiopharmaceutical Company, Product Type & Application
  7. 3.7 Global Radiopharmaceutical Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Radiopharmaceutical Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Radiopharmaceutical Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Radiopharmaceutical Tier 1, Tier 2, and Tier 3
4 Radiopharmaceutical Regional Status and Outlook
  1. 4.1 Global Radiopharmaceutical Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Radiopharmaceutical Historic Market Size by Region
  3. 4.2.1 Global Radiopharmaceutical Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Radiopharmaceutical Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Radiopharmaceutical Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Radiopharmaceutical Forecasted Market Size by Region
  7. 4.3.1 Global Radiopharmaceutical Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Radiopharmaceutical Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Radiopharmaceutical Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Radiopharmaceutical by Application
  1. 5.1 Radiopharmaceutical Market by Application
  2. 5.1.1 Oncology
  3. 5.1.2 Cardiology
  4. 5.1.3 Other
  5. 5.2 Global Radiopharmaceutical Market Size by Application
  6. 5.2.1 Global Radiopharmaceutical Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Radiopharmaceutical Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Radiopharmaceutical Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Radiopharmaceutical Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Radiopharmaceutical Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Radiopharmaceutical Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Radiopharmaceutical Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Radiopharmaceutical Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bracco Imaging
  2. 6.1.1 Bracco Imaging Company Information
  3. 6.1.2 Bracco Imaging Business Overview
  4. 6.1.3 Bracco Imaging Radiopharmaceutical Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bracco Imaging Radiopharmaceutical Product Portfolio
  6. 6.1.5 Bracco Imaging Recent Developments
  7. 6.2 Bayer
  8. 6.2.1 Bayer Company Information
  9. 6.2.2 Bayer Business Overview
  10. 6.2.3 Bayer Radiopharmaceutical Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bayer Radiopharmaceutical Product Portfolio
  12. 6.2.5 Bayer Recent Developments
  13. 6.3 Mallinckrodt
  14. 6.3.1 Mallinckrodt Company Information
  15. 6.3.2 Mallinckrodt Business Overview
  16. 6.3.3 Mallinckrodt Radiopharmaceutical Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mallinckrodt Radiopharmaceutical Product Portfolio
  18. 6.3.5 Mallinckrodt Recent Developments
  19. 6.4 Nordion
  20. 6.4.1 Nordion Company Information
  21. 6.4.2 Nordion Business Overview
  22. 6.4.3 Nordion Radiopharmaceutical Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Nordion Radiopharmaceutical Product Portfolio
  24. 6.4.5 Nordion Recent Developments
  25. 6.5 Triad Isotopes
  26. 6.5.1 Triad Isotopes Company Information
  27. 6.5.2 Triad Isotopes Business Overview
  28. 6.5.3 Triad Isotopes Radiopharmaceutical Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Triad Isotopes Radiopharmaceutical Product Portfolio
  30. 6.5.5 Triad Isotopes Recent Developments
  31. 6.6 Lantheus
  32. 6.6.1 Lantheus Company Information
  33. 6.6.2 Lantheus Business Overview
  34. 6.6.3 Lantheus Radiopharmaceutical Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Lantheus Radiopharmaceutical Product Portfolio
  36. 6.6.5 Lantheus Recent Developments
  37. 6.7 IBA Group
  38. 6.7.1 IBA Group Company Information
  39. 6.7.2 IBA Group Business Overview
  40. 6.7.3 IBA Group Radiopharmaceutical Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 IBA Group Radiopharmaceutical Product Portfolio
  42. 6.7.5 IBA Group Recent Developments
  43. 6.8 GE Healthcare
  44. 6.8.1 GE Healthcare Company Information
  45. 6.8.2 GE Healthcare Business Overview
  46. 6.8.3 GE Healthcare Radiopharmaceutical Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 GE Healthcare Radiopharmaceutical Product Portfolio
  48. 6.8.5 GE Healthcare Recent Developments
  49. 6.9 China Isotope & Radiation
  50. 6.9.1 China Isotope & Radiation Company Information
  51. 6.9.2 China Isotope & Radiation Business Overview
  52. 6.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 China Isotope & Radiation Radiopharmaceutical Product Portfolio
  54. 6.9.5 China Isotope & Radiation Recent Developments
  55. 6.10 Jubilant Pharma
  56. 6.10.1 Jubilant Pharma Company Information
  57. 6.10.2 Jubilant Pharma Business Overview
  58. 6.10.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Jubilant Pharma Radiopharmaceutical Product Portfolio
  60. 6.10.5 Jubilant Pharma Recent Developments
  61. 6.11 Eli Lilly
  62. 6.11.1 Eli Lilly Company Information
  63. 6.11.2 Eli Lilly Business Overview
  64. 6.11.3 Eli Lilly Radiopharmaceutical Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Eli Lilly Radiopharmaceutical Product Portfolio
  66. 6.11.5 Eli Lilly Recent Developments
  67. 6.12 Advanced Accelerator Applications
  68. 6.12.1 Advanced Accelerator Applications Company Information
  69. 6.12.2 Advanced Accelerator Applications Business Overview
  70. 6.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Advanced Accelerator Applications Radiopharmaceutical Product Portfolio
  72. 6.12.5 Advanced Accelerator Applications Recent Developments
  73. 6.13 SIEMENS
  74. 6.13.1 SIEMENS Company Information
  75. 6.13.2 SIEMENS Business Overview
  76. 6.13.3 SIEMENS Radiopharmaceutical Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 SIEMENS Radiopharmaceutical Product Portfolio
  78. 6.13.5 SIEMENS Recent Developments
  79. 6.14 Dongcheng
  80. 6.14.1 Dongcheng Company Information
  81. 6.14.2 Dongcheng Business Overview
  82. 6.14.3 Dongcheng Radiopharmaceutical Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Dongcheng Radiopharmaceutical Product Portfolio
  84. 6.14.5 Dongcheng Recent Developments
  85. 6.15 Navidea
  86. 6.15.1 Navidea Company Information
  87. 6.15.2 Navidea Business Overview
  88. 6.15.3 Navidea Radiopharmaceutical Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Navidea Radiopharmaceutical Product Portfolio
  90. 6.15.5 Navidea Recent Developments
7 North America by Country
  1. 7.1 North America Radiopharmaceutical Sales by Country
  2. 7.1.1 North America Radiopharmaceutical Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Radiopharmaceutical Sales by Country (2021-2026)
  4. 7.1.3 North America Radiopharmaceutical Sales Forecast by Country (2027-2032)
  5. 7.2 North America Radiopharmaceutical Market Size by Country
  6. 7.2.1 North America Radiopharmaceutical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Radiopharmaceutical Market Size by Country (2021-2026)
  8. 7.2.3 North America Radiopharmaceutical Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Radiopharmaceutical Sales by Country
  2. 8.1.1 Europe Radiopharmaceutical Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Radiopharmaceutical Sales by Country (2021-2026)
  4. 8.1.3 Europe Radiopharmaceutical Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Radiopharmaceutical Market Size by Country
  6. 8.2.1 Europe Radiopharmaceutical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Radiopharmaceutical Market Size by Country (2021-2026)
  8. 8.2.3 Europe Radiopharmaceutical Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Radiopharmaceutical Sales by Country
  2. 9.1.1 Asia-Pacific Radiopharmaceutical Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Radiopharmaceutical Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Radiopharmaceutical Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Radiopharmaceutical Market Size by Country
  6. 9.2.1 Asia-Pacific Radiopharmaceutical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Radiopharmaceutical Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Radiopharmaceutical Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Radiopharmaceutical Sales by Country
  2. 10.1.1 South America Radiopharmaceutical Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Radiopharmaceutical Sales by Country (2021-2026)
  4. 10.1.3 South America Radiopharmaceutical Sales Forecast by Country (2027-2032)
  5. 10.2 South America Radiopharmaceutical Market Size by Country
  6. 10.2.1 South America Radiopharmaceutical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Radiopharmaceutical Market Size by Country (2021-2026)
  8. 10.2.3 South America Radiopharmaceutical Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Radiopharmaceutical Sales by Country
  2. 11.1.1 Middle East and Africa Radiopharmaceutical Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Radiopharmaceutical Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Radiopharmaceutical Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Radiopharmaceutical Market Size by Country
  6. 11.2.1 Middle East and Africa Radiopharmaceutical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Radiopharmaceutical Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Radiopharmaceutical Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Radiopharmaceutical Value Chain Analysis
  2. 12.1.1 Radiopharmaceutical Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Radiopharmaceutical Production Mode & Process
  7. 12.2 Radiopharmaceutical Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Radiopharmaceutical Distributors
  10. 12.2.3 Radiopharmaceutical Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst